Moderate evidence
Better sleep
The National Academies found moderate evidence that cannabinoids improve short-term sleep in people with sleep disturbance linked to sleep apnea, fibromyalgia, chronic pain, and MS11. In a 2021 randomized trial, a nightly cannabinoid extract added about an hour of self-reported sleep for people with chronic insomnia98.
Emerging evidence
PTSD
In a year-long prospective study, people with PTSD who used dispensary cannabis saw bigger drops in symptoms. They were 2.57 times more likely to no longer meet PTSD criteria by the end than non-users44. A systematic review found cannabinoids may help with PTSD anxiety, memory processing, and sleep45. Researchers are now calling for larger randomized trials.
Emerging evidence
Anxiety
CBD improved anxiety in people with social anxiety disorder during a public-speaking test11 97, and the lesser-known cannabinoid CBG reduced anxiety and stress in a 2024 placebo-controlled trial113. Researchers see these as early, encouraging signals.
Emerging evidence
Crohn's disease (IBD)
In a placebo-controlled trial, 10 of 11 patients with active Crohn's given THC-rich cannabis had a clinical response, versus 4 of 10 on placebo. Three patients came off steroid dependence, and patients reported better appetite and sleep43.
Emerging evidence
Tourette syndrome
The National Academies reported limited evidence that THC capsules improve Tourette symptoms11.
Emerging evidence
Recovering from brain injury
The National Academies found limited evidence linking cannabinoids to better outcomes, including survival, after traumatic brain injury or brain bleeding11.